A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney, R E
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. [electronic resource] - The Journal of pediatrics Oct 1998 - 500-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0022-3476
10.1016/s0022-3476(98)70057-5 doi
Adolescent
Anti-HIV Agents--therapeutic use
CD4 Antigens--immunology
Child
Child, Preschool
Didanosine--therapeutic use
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
HIV Infections--complications
HIV-1
Humans
Lamivudine--therapeutic use
Male
Neurodegenerative Diseases--etiology
Polymerase Chain Reaction--methods
RNA, Viral--immunology
Survival Rate
Zidovudine--therapeutic use
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. [electronic resource] - The Journal of pediatrics Oct 1998 - 500-8 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0022-3476
10.1016/s0022-3476(98)70057-5 doi
Adolescent
Anti-HIV Agents--therapeutic use
CD4 Antigens--immunology
Child
Child, Preschool
Didanosine--therapeutic use
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Female
Follow-Up Studies
HIV Infections--complications
HIV-1
Humans
Lamivudine--therapeutic use
Male
Neurodegenerative Diseases--etiology
Polymerase Chain Reaction--methods
RNA, Viral--immunology
Survival Rate
Zidovudine--therapeutic use